NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that the University of Pittsburgh will use its SmartChip Real-Time PCR System in genomics, gene expression, and disease studies that are funded by the National Institutes of Health.
The Pittsburgh researchers are using $350,000 of a $3.5 million American Recovery and Reinvestment Act grant to support their efforts. The award is partially funding two research programs conducted under a collaboration with Pittsburgh, Harvard University, Boston University, National Jewish Hospital, and Wake Forest University.
One program aims to create a genetic, molecular, and quantitative clinical phenotyping data warehouse that will be used in studies of disease pathogenesis and help refine diagnostic criteria for use in addressing chronic lung disease. Another genomics project will focus on understanding why some individuals with asthma are more difficult to treat than others.
Both of these projects will use the SmartChip technology for high-throughput PCR validation, the company said.